Pub1 | Pub2 | Prv1 (NGO) | Prv2 (GP) | Prv3 (Nurse)* | ||||||
---|---|---|---|---|---|---|---|---|---|---|
n=76 | n=75 | n=75 | n=75 | n=75 | ||||||
Outcome, mean (SD) | ||||||||||
All patients | 297 | (115) | 195 | (86) | 358 | (200) | 247 | (85.29) | 97 | (71) |
In care for HIV, all | 335 | 238 | 489 | 287 | 206 | |||||
In care & VL suppressed | 342 | (78) | 244 | (53) | 487 | (112) | 293 | (29.52) | 0 | (0) |
In care & VL unsuppressed | 295 | (116) | 257 | (8) | 486 | (51) | 270 | (40.93) | 0 | (0) |
In care & VL unknown | 319 | (102) | 230 | (36) | 497 | (126) | 261 | (23.23) | 206 | (96) |
Not in care for HIV, all | 142 | (96) | 76 | (51) | 138 | (95) | 110 | (65.18) | 88 | (60) |
Cost category for in care, mean (%) | ||||||||||
Drugs - ARV | 90 | (27%) | 94 | (39%) | 101 | (21%) | 87 | (30%) | 144 | (70%) |
Drugs - non ARV | 16 | (5%) | 5 | (2%) | 19 | (4%) | 17 | (6%) | 4 | (2%) |
Laboratory tests | 59 | (18%) | 39 | (16%) | 65 | (13%) | 48 | (17%) | 0 | (%) |
Non variable costs | 170 | (51%) | 100 | (42%) | 305 | (62%) | 136 | (47%) | 58 | (28%) |
Staff - Clinical | 113 | (34%) | 62 | (26%) | 117 | (24%) | 0 | (0%) | 0 | (0%) |
Staff - Non clinical | 17 | (5%) | 23 | (10%) | 108 | (22%) | 0 | (0%) | 0 | (0%) |
Fixed costs | 40 | (12%) | 15 | (6%) | 79 | (16%) | 0 | (0%) | 0 | (0%) |
Fixed fee** | 0 | (0%) | 0 | (0%) | 0 | (0%) | 136 | (47%) | 58 | (28%) |
Total | 335 | (100%) | 238 | (100%) | 489 | (100%) | 287 | (100%) | 206 | (100%) |
Summary costs for in care | ||||||||||
Total cost per month in care, mean (SD) | 31 | (7) | 20 | (4) | 47 | (13) | 29 | (14) | 44 | (21) |
Non variable cost per visit | 20 | 10 | 32 | 17 | 13 |